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Summary A human colon cancer cell line, OCUC-LM1(LM), was established from a liver metastasis in our laboratory. Intrasplenic injection
of LM into nude mice was repeated three and five times, and the daughter cell lines were designated as LM-H3 and LM-H5 respectively. The
level of sialyl Lewis A (SLA) in the supernatant of LM-H3 and LM-H5 was 3 and 4.5 times higher than that of LM respectively. Flow cytometric
analysis of SLA expression showed that the peak channel for LM was 113; for LM-H3, 126; and for LM-H5, 146. The mean fluorescence
intensity of LM was 102.3 ± 43.5; for LM-H3, 126.2 ± 28.4; and for LM-H5, 144.8 ± 23.4. In endothelial cell adhesion assays, the percentages
of adherent LM-H3 and LM-H5 cells were significantly higher than for LM. The activity of al -4 fucosyltransferase was higher in LM-H3 and
LM-H5 than in LM, but there was no difference in a2-*3 sialyltransferase activities for type 1 chain among the cell lines. Our results suggest
that SLA expression is associated with acquisition of a high capacity for liver metastasis of colon cancer; increased SLA expression is due
mainly to increased fucosyltransferase activity.
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The incidence of colorectal cancer has increased recently, and the
presence of metastasis is one of the most critical factors in deter-
mining the prognosis of colorectal cancer patients. The patho-
physiology of metastasis is one of the most important issues in
tumour biology. Recent animal studies have shown that highly
metastatic tumour cells have biochemical properties different from
those ofpoorly metastatic cells. A variety ofcarbohydrate antigens
are known to be expressed frequently on human colorectal cancer
cells. These carbohydrate antigens have been used as tumour
markers for preoperative diagnosis of colon cancer. Carbohydrate
antigens may affect cellular adhesiveness (Irimura et al, 1981;
Dennis et al, 1982), immunogenicity, other immune recognition
mechanisms (Gendler et al, 1988), induction of platelet aggrega-
tion (Pearlstein et al, 1980; Kjima-Suda et al, 1986), invasive
characteristics (Bolscher et al, 1980) and probably other yet unde-
scribed cellular behaviours that may affect the metastatic potential
oftumour cells.
It has been reported recently that some carbohydrate antigens
play significant roles in the adhesion ofcancer cells to endothelial
cells. For example, sialyl Lewis X (SLX) (Lowe et al, 1990;
Phillips et al, 1990; Waiz et al, 1990; Tiemeyer et al, 1991) and
sialyl Lewis A (SLA) (Berg et al, 1991; Takada et al, 1991a;
Tyrrell et al, 1991) have been shown to be specific ligands for
E-selection (ELAM-1, endothelial leukocyte adhesion molecule 1),
which is expressed in vascular endothelium, and they may
be involved in adhesion between cancercells and endothelial cells.
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It is well known that SLX and SLA are frequently expressed in
colorectal cancer, and there are many reports available concerning
the expression of carbohydrate structures in primary colorectal
carcinomas (Atkinson et al, 1982; Gong et al, 1985; Itzkowitz et al,
1986). We have found previously that SLA was expressed on a
largerproportion oftumourcells in livermetastases than inprimary
colorectal cancers (Yamadaetal, 1995a). Webelieve thatcolorectal
carcinoma cells expressing SLA detach from primary tumours,
invade blood vessels, adhere to vascular endothelium and grow into
metastatic tumours. An increase in SLA may be the result ofpref-
erential colonization and growth ofatumour subpopulation thathas
these antigenic properties at the sites of metastases. Alternatively,
biosynthesis ofthis antigen might be potentiated by microenviron-
mental factors at the sites of metastases. It is not clear whether the
increased expression of SLA in metastatic tissues is due to an
increased number of cells producing this antigen or to increased
antigen content per cell. In this report, we describe changes in
carbohydrate antigens, adhesiveness to endothelium and glycosyl-
transferase activity during acquisition of a high capacity of liver
metastasis in a human colon cancer cell line.
MATERIALS AND METHODS
Cell line
A new human colon cancer cell line, designated OCUC-LM1(LM),
was established from a liver metastasis in our laboratory. LM cells
proliferate in a monolayered sheet with a population doubling time
of 29.4 h. The DNA ploidy pattern of LM was aneuploid and the
DNA index was 1.55. LM cells express the tumour-associated
antigens CEA, SLA, and SLX. Subcutaneous injections ofLM cells
induced tumour formation in nude mice, and the reconstituted
tumour was a moderately differentiated adenocarcinoma.
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Establishment of a highly metastatic cell line
Nude mice were anaesthetized with ethyl ether. The abdominal
wall was incised, and the spleen was exposed. A total of 1 x 106
LM cells suspended in 0.1 ml of phosphate-buffered saline (PBS)
were injected into the lower pole of the spleen. Splenectomy was
performed after splenic injection and the abdominal wall and skin
were closed with a continuous suture. The mice were killed
4 weeks after the injection. Metastasis to the liver was evaluated as
the number oftumour nodules in the liver. Several liver metastases
were dissected free and minced into small pieces; the cell suspen-
sion was recultured in 10% fetal calf serum-Dulbecco's modified
Eagle medium (FCS-DMEM). When the cultures became semi-
confluent, cells were collected, diluted to 1.0 x 106 cells 0.1 ml'
and again injected into the spleen of nude mice. This procedure
was repeated three and five times, and the daughter cell lines were
designated as LM-H3 and LM-H5 respectively. All procedures
involving animals were conducted in accordance with the
UKCCCR guidelines for the welfare of animals in experimental
neoplasia.
Tumour-associated antigen secretion
The secretion of tumour-associated antigens was studied in
supematants collected from cells cultured for 5 days. The SLX
and SLA levels in the supernatant were determined by SLX
Otsuka kit (Otsuka Assay Laboratories, Tokushima, Japan) and
SLA RIA kit (Centocor, Malvern, PA, USA) respectively. The
CEA level was determined by CEA RIABEAD kit (Dainabot,
Tokyo, Japan).
Flow cytometric analysis of SLA and SLX expression
Flow cytometric analysis was performed using the EPICS-C
(Coulter Electronics). Human colon cancer cells were
incubated for 30 min at room temperature with NS19-9 orFH6 as
primary antibody at the concentration of 1.0 jg ml-' per
1.0 x 106 cells ml-'. Cells were washed twice with PBS and
incubated for 30 min at room temperature with fluorescein
isothiocyanate-labelled goat anti-murine lgG or IgM antibody
as secondary antibody. Cells were washed and resuspended
for analysis on the flow cytometer.
Cell adhesion assay
Human umbilical vein endothelial cells (HUVECs; Kurabou,
Osaka, Japan) were stimulated with 1 ng ml-' recombinant inter-
leukin 13 (rlLl-P; Central Research Laboratory of Otsuka
Pharmaceutical, Tokushima, Japan) for4 h in 96-well microplates.
LM, LM-H3 and LM-H5 cells (1.0 x 106 cells ml-') were added to
the activated HUVECs and incubated for 30 min at room tempera-
ture with rotation. After incubation, the microplates were gently
washed twice with PBS to remove unattached cells, and adherent
cells were detected by incubating with 0.5 mg ml-' MTT [3-(4,5-
dimethylthiazol)-2,5-diphenyl tetrazolium bromide, Sigma] for
3 h at 37°C. The formazans were solubilized with dimethyl
sulphoxide (DMSO) from Wako, Osaka, Japan, and measured with
an automated microplate reader (EAR340, SLT, Austria). The
percentage adhesion, i.e. the absorbance of the adherent cells to
HUVECs divided by the absorbance of the whole cells added to
HUVECs was measured.
Inhibition assay
HUVECs were preincubated with anti-E-selectin antibody
(50 jg ml-') for 30 min at 37°C before the adhesion assay to inves-
tigate the contribution of E-selectin to adhesion. Similarly, LM,
LM-H3 and LM-H5 cells were preincubated with NS19-9 (50 g
ml-') for 30 min at 37°C before the adhesion assay to investigate
the contribution of SLA to adhesion. Inhibition of adhesion in this
assay was estimated as the percentage adhesion, i.e. the absorbance
of the adherent cells to HUVECs after pretreatment with anti-E-
selectin antibody or NS19-9 divided by the absorbance ofcontrols.
Measurement of fucosyltransferase activity
Cell pellets were homogenized with an ultrasonic disrupter
(TOMY) in homogenizing buffer containing 250 mm sucrose and
10 mM Tris-HCl buffer, pH 7.4. Acceptor oligosaccharides were
fluorescence labelled with 2-aminopyridine, according to methods
described previously (Kondo et al, 1990). The pyridylaminated
derivatives of SA-Lc4 and SA-nLc4 were used as acceptors
for al-4 fucosyltransferase and al-3 fucosyltransferase,
producing SLA and SLX respectively according to methods
described previously (Dohi et al, 1994).
Measurement of sialyltransferase activity
Cell pellets were homogenized, and acceptor oligosaccharides
were fluorescence labelled with 2-aminopyridine as above. The
pyridylaminated derivatives of Lc4 and nLc4 were used as accep-
tors for a2-+3 sialyltransferase according to methods described
previously (Sasaki et al, 1993).
Statistical analysis
Values are given as the means ± standard deviation of at least four
independent determinations. Differences were assessed using
Student's t-test, with significance taken at P < 0.05.
RESULTS
Establishment of a highly metastatic liver cell line
Four weeks after splenic injection of LM cells, liver metastases
were observed in two offour nude mice. In contrast, 4 weeks after
splenic injection of LM-H3 and LM-H5 cells, liver metastases
were observed in all four nude mice tested. The numbers of liver
metastases with LM in four nude mice were 0, 0, 69 and 178,
whereas metastases ofLM-H3 and LM-H5 were uncountable. The
liver weight of nude mice injected with LM cells averaged
1.64 ± 0.30 g; for LM-H3 4.48 ± 0.47 g; and for LM-H5,
4.95 ± 1.15 g (Table 1).
Tumour-associated antigen secretion
The levels of tumour-associated antigens secreted into the condi-
tioned medium ofLM, LM-H3 and LM-H5 are shown in Table 2.
High levels ofSLA and CEA and low levels ofSLX were found in
the spent medium ofLM. CEA level in the spent media ofLM-H3
and LM-H5 were similar to LM, but the SLA level in the spent
medium ofLM-H3 was three times as high as that ofLM, and LM-
H5 was 4.5 times higher than LM.
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Table 1 Production of liver metastasis by LM, LM-H3 and LM-H5 cells
injected into the spleen of nude mice
Cell line Number of mice with Number of Liver weight
liver metastasisltotal liver colonies (g)
LM 2/4 0,0,69,178 1.64±0.30
LM-H3 4/4 Uncountable 4.48 ±0.47*
LM-H5 4/4 Uncountable 4.95 ± 1.15*
*P< 0.005
SLX
Control
LM
A LM-H3
LM-H5
Table 2 Tumour-associated antigens in the spent media of LM, LM-H3 and
LM-H5
SLX (U ml-1) SLA (U ml-') CEA (ng ml-1)
LM 40 1669 463
LM-H3 65 4800 300
LM-H5 82 7300 500
SLA
I
I
I
I
I
I
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I
I
I
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Figure 1 Flow cytometric analysis of the expression of SLX and SLA on LM, LM-H3 and LM-H5
Flow cytometric analysis of SLA and SLX expression
No lines expressed SLX, all three expressed SLA intensively on
the cell surface. The peak channel for LM was 113; for LM-H3,
126; and for LM-H5, 146. The MFI (mean fluorescence intensity)
of LM was 102.3 + 43.5; for LM-H3, 126.2 + 28.4; and for LM-
H5, 144.8 ± 23.4 (Figure 1).
Adhesion of LM, LM-H3 and LM-H5 cells to endothelial
cells
Adhesion ofLM-H3 and LM-H5 was significantly higher than that
of LM, but there was no difference between LM-H3 and LM-H5
(Figure 2). The percentages of adherent cells were as follows: LM
21.8 ± 1.3; LM-H3 42.9 ± 2.8; and LM-H5 39.8 ± 2.3.
Inhibition of cell adhesion by anti-E-selectin and anti-
SLA antibodies
In all cases, adhesion ofLM, LM-H3 and LM-H5 cells to endothe-
lial cells was inhibited significantly by both anti-E-selectin and
anti-SLA antibodies (Figure 3).
Fucosyltransferase activity
The activities of cxl-4 fucosyltransferase were as follows: LM
26.6, LM-H3 187.6 and LM-H5 171.7. The activities of cxl-*3
fucosyltransferase were as follows: LM 13.8, LM-H3 52.5 and
LM-H5 156.6. Both cxl-4 fucosyltransferase activity and cXl-3
fucosyltransferase activity were significantly higher in LM-H3 and
LM-H5 than in LM (Table 3).
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Figure 2 Adhesion of LM, LM-H3 and LM-H5 cells to endothelial cells.
Asterisk denotes statistically significant differences compared with LM
(P < 0.001)
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Table 3 Activity of fucosyltransferase (FT) (pmol h-1 mg-' protein)
Cell line al-4FT to type 1 chain a 1-3FT to type 2 chain
LM 26.6 13.8
LM-H3 187.6 52.5
LM-H5 171.7 156.6
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40
20
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80-
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40-
20
Table 4 Activity of ac2-3 sialyltransferase (ST) (pmol h-1 mg-' protein)
Cell line ST to type 1 chain ST to type 2 chain
LM 11.7 76.6
LM-H3 7.4 32.5
LM-H5 10.4 23.7
Sialyltransferase activity
The activities of a2-*3 sialyltransferase to type 1 chain were as
follows: LM 11.7, LM-H3 7.4 and LM-H5 10.4. The activities of
a2-*3 sialyltransferase to type 2 chain were as follows: LM 76.6,
LM-H3 32.5 and LM-H5 23.7 (Table 4). There was no difference
in the activities of a2->3 sialyltransferase to type 1 chain among
the cell lines, but the activities ofa2-+3 sialyltransferase to type 2
chain decreased as these cell lines acquired metastatic potential.
DISCUSSION
SLA is a cancer-associated carbohydrate antigen frequently
expressed in cancers ofthe digestive tract, such as colon, pancreas
and biliary tract. Our results indicate that SLA expression
increases as the metastatic potential of the cell line increases. In
addition, our results suggest that the increased SLA expression is
not due to an increased number ofcells producing this antigen but
rather to increased antigen content per cell. Previously, we used
immunohistochemical methods to estimate the relative amounts of
SLA in primary colorectal tumours and matched liver metastases.
Those results indicated that SLA was expressed on a higher
proportion of tumour cells in liver metastases than in primary
tumours. However, in the current study, there was no difference in
the proportion of cells producing SLA in the three cell lines. This
may be because LM is established not from a primary lesion, but
from a metastatic liver lesion. In fact, LM has some metastatic
Tl*
*~~~~~~~~~~~~~~~~
Control Anti-E-selectin
LM-H3
Anti-SLA
T ** T*
Control Anti-E-selectin Anti-SLA
U. J
LM-H5
T *
*
Control Anti-E-selectin Anti-SLA
Figure 3 Effects of anti-E-selectin and anti-SLA antibodies on the adhesion
of LM, LM-H3 and LM-H5 cells to endothelial cells. A single asterisk denotes
a statistically significant difference from control value (P < 0.05) and double
asterisks denote a statistically significant difference from control value
(P < 0.005)
potential. SLA expression on LM-H3 and LM-H5 was increased
compared with LM, and this increased expression was correlated
with a high capacity for metastasis.
Our results also indicated that adhesiveness to endothelium by
highly metastatic cell lines was significantly increased over the
parental cell line. Alterations in cell-surface glycoproteins are
common during carcinogenesis and may play a key role in deter-
mining the metastatic behaviour of tumour cells (Nicolson, 1982;
Roos, 1984; Schirrmacher, 1985; Raz and Lotan, 1987). Recently,
E-selectin has been reported to recognize sialyl Lewis X (Lowe et
al, 1990; Phillips et al, 1990; Waiz et al, 1990; Tiemeyer et al, 1991)
and sialyl Lewis A (Berg et al, 1991; Takada et al, 1991b; Tyrrell
et al, 1991) as ligands, and these carbohydrate antigens may be
involved in adhesion between cancer cells and endothelial cells that
results in metastasis. Expression of E-selectin on the surface of
endothelial cells occurs principally in response to cytokines, such as
TNF and IL-1 (Bevilacqua and Nelson, 1993), as part of an
inflammatory response. One might speculate whether the proper
conditions forendothelial cell activation are present early in tumori-
genesis. It is possible that tumour cells themselves produce
autocrine factors that induce E-selectin, independent of a general
inflammatory response. Indeed, certain highly metastatic liver cell
lines produce IL-I and/or IL-6 (Takada et al, 199lb); LM, LM-H3,
British Journal ofCancer (1997) 76(5), 582-587
0
n
0CancerResearch Campaign 1997586 N Yamada etal
GIcNAc-R
131,4a 3Gal TF
Gal 1-4GlcNAc-R Gal 1l-3GIcNAc-R
a 2,3NeuAc TF a 2,3NeuAc TF
NeuAc a 2-3 Gal 31-4GIcNAc-R NeuAc a 2-3 Gal P 1-3GlcNAc-R
a 1,3FucTF a 1,4Fuc TF
NeuAc a 2-3 Gal 13 -4GlcNAc-R NeuAc a 2-3 Gal 1 1-3GlcNAc-R
3 4
Fuca1 Fucal
Sialyl Lewis X Sialyl LewisA
(type 2 chain) (type 1 chain)
Figure 4 Biosynthetic pathway of SLX and SLA. R, core carbohydrate
structure; TF, glycoslytransferase
and LM-H5 secrete IL-5 into the spent medium (data not shown).
However, there was no difference in the amount of IIL-, among
these cell lines. Increased adhesion of highly metastatic cell lines
may be due to increased SLA expression. Although adhesiveness of
LM-H3 and LM-H5 was significantly higher than that ofLM, there
was no difference in adhesiveness between LM-H3 and LM-H5,
despite higher expression of SLA on LM-H5. It is possible that
adhesion reaches aplateau below the amount ofSLA expression on
LM-H3. It is also possible that other adhesion molecules contribute
to this adhesion. SLX and SLA are known to be ligands for E-
selectin, but it is likely that other carbohydrate antigens can also
serve as ligands for E-selectin. We reported previously that SPan-l
antigen might play a significant role in E-selectin binding by
colorectal cancer cells (Yamada et al, 1995b), and Kunzendorf et al
(1994) havereported an as yetundefinedligand, different from SLX
or SLA, that enabled melanoma cells to adhere to E-selectin.
Finally, our results indicate that fucosyltransferase activities of
highly metastatic cell lines are increased overtheparental cell line,
whereas no differences in sialyltransferase activity are found. As
shown in Figure 4, many glycosyltransferases participate in the
biosynthesis of SLA and SLX, and there are many branch points
yielding different carbohydrate determinants. The final expression
of carbohydrate epitopes is determined by the relative levels of
these enzymes. Our cell lines strongly expressed SLA, although
expression of SLX was weak or undetectable, suggesting that
PI-+3 galactosyltransferase activity may be much stronger than
PI-+4 activity in these cell lines.
Sialyltransferases are a family of more than ten enzymes that
catalyse the transferofsialic acidfrom CMP-sialic acid to terminal
positions on sugar chains of glycoproteins and glycolipids. Sialic
acids are key determinants of carbohydrate structures that play
important roles in a variety ofbiological processes, and expression
ofsialoglycoproteins is controlled in part by sialyltransferase. The
amount of sialic acid on the surface of malignant cells has been
correlated with the ability of these cells to metastasize
(Yogeeswaran, 1983; Passaniti and Hart, 1988). Harvey et al,
(1992) have shown that increased cell-surface sialic acid is associ-
ated with malignant transformation, and increased metastatic cells
contain higher levels of sialyltransferase, hence higher levels of
sialic acid were more likely to form tumours in the liver. However,
we found no differences in a2-3 sialyltransferase activities
among our cell lines. Our findings do not prove that increased
sialyltransferase activity causes the increased expression of SLA
on the surface ofhighly metastatic cell lines.
The biosynthesis of SLA or SLX is completed by al-*3 or
cxl-4 fucosyltransferase, which transfers fucose to the penulti-
mate N-acetylglucosamine of Gal,B1-4/3GlcNAc-R residue,
where the termninal galactose is derived from NeuAca2->3
linkage. Molecular cloning ofseveral types offucosyltransferases,
which are responsible for the expression of enzymes generating
the SLX determinant, has been accomplished (Kukowska-Latallo
et al, 1990; Weston et al, 1992a,b). One enzyme type is thought to
contribute to synthesis of the SLA determinant. Our results indi-
cate that the activity ofal-4 fucosyltransferase is greater in LM-
H3 and LM-H5 than in LM; increased al->4 fucosyltransferase
activity is the cause ofincreased expression of SLA on the surface
of our highly metastatic cell lines. There may be many other
factors controlling SLA expression, such as glycosyltransferases,
glycosidases and other molecules modulating enzyme activities.
We conclude that SLA expression is increased with the acquisi-
tion ofahigh capacity for liver metastasis by colon cancer, and the
increased expression of SLA is due mainly to increased fucosyl-
transferase activity.
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